pharma · Glaucoma · Macular Edema
Allergan Pharmaceuticals International
Allergan Pharmaceuticals International Limited
Allergan Pharmaceuticals International patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Dublin, IE
- Programs
- 0
- Drugs
- 9
- Patents
- 1
Allergan Pharmaceuticals International patents
1 pharmaceutical patents indexed for Allergan Pharmaceuticals International. 0 expire within 24 months.
Allergan Pharmaceuticals International has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Allergan Pharmaceuticals International have?
1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Allergan Pharmaceuticals International patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.